← FDA Drug Approvals (Drugs@FDA)
LYTGOBI
NDA · New Drug Application · Sponsor: TAIHO ONCOLOGY · Approved 2022-09-30
Drug application
- FDA Application #
NDA214801- Application type
- New Drug Application
- Brand name
- LYTGOBI
- Generic name
- Futibatinib
- Active ingredients
- FUTIBATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TAIHO ONCOLOGY
- First approval
- 2022-09-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown